CyclophosphamideGuaranteedRenewableInsuranceChemopreventionMRIAnastrozoleACChemotherapyCytotoxicOvarianSuppressionTamoxifenRadiotherapyIn-situCarcinomaHER-2CheckpointInhibitorMultimodalityTherapyMethotrexateAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltGermlineMutationAyurvedaTyrosine-KinaseInhibitorPalpation5-FluorouracilTriple +/-BreastCancerCytostaticDoseDenseTherapyMastodyniaDown-StagingEstrogenMorpheaBevacizumabCMFChemotherapyER-CDK4/6InhibitorsOligometastasesKappaEpsilonDimplingLymphNodeStatusAlopeciaMetastasisFibroadenomaLCISHerceptinRaloxifeneFamilyHistoryStagingAdjuvantTherapyLymphoscintigraphyAbsoluteRiskSelf-examinationPalbociclibPagetDiseaseAntibodyTherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.HormoneReceptorStatusChemotherapyCystEGFRPaclitaxelPathologicResponseAntiemeticDefinitiveSurgeryBreastTomosynthesisPARPInhibitorsRADNeoadjuvantTherapyApoptosisBI-RADSTumorGrade1 in 8womenAxillarySamplingProgestinMultifocalTumorsLapatinibFISHER+PI3KinaseInhibitorsWomen ages40+ shouldhave a clinicalbreast examat least yearlyBilateralProphylacticMastectomyGenomicTestingCapecitabineBreastCancerBOCABrachytherapyCalcificationsSERMHormoneReplacementTherapyPrecisionMedicineGailModelGeneticPredispositionKi-67RateLumpPhyllodesTumorGeneticCounselingDocetaxelBiopsyMastectomyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Co-survivorDoxorubicinECOGScoreAdenocarcinomaLumpectomyRelapseAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenImmunotherapyCAMEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearGeneMutationEstradiolBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55mTORInhibitorsCachexiaAdvocacyAromataseInhibitorsFlowCytometryMegestrolAcetatePhysicalactivity mayreduce therisk of breastcancersBRCAGeneAngiogenesisIntraductalPapillomaCyclophosphamideGuaranteedRenewableInsuranceChemopreventionMRIAnastrozoleACChemotherapyCytotoxicOvarianSuppressionTamoxifenRadiotherapyIn-situCarcinomaHER-2CheckpointInhibitorMultimodalityTherapyMethotrexateAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltGermlineMutationAyurvedaTyrosine-KinaseInhibitorPalpation5-FluorouracilTriple +/-BreastCancerCytostaticDoseDenseTherapyMastodyniaDown-StagingEstrogenMorpheaBevacizumabCMFChemotherapyER-CDK4/6InhibitorsOligometastasesKappaEpsilonDimplingLymphNodeStatusAlopeciaMetastasisFibroadenomaLCISHerceptinRaloxifeneFamilyHistoryStagingAdjuvantTherapyLymphoscintigraphyAbsoluteRiskSelf-examinationPalbociclibPagetDiseaseAntibodyTherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.HormoneReceptorStatusChemotherapyCystEGFRPaclitaxelPathologicResponseAntiemeticDefinitiveSurgeryBreastTomosynthesisPARPInhibitorsRADNeoadjuvantTherapyApoptosisBI-RADSTumorGrade1 in 8womenAxillarySamplingProgestinMultifocalTumorsLapatinibFISHER+PI3KinaseInhibitorsWomen ages40+ shouldhave a clinicalbreast examat least yearlyBilateralProphylacticMastectomyGenomicTestingCapecitabineBreastCancerBOCABrachytherapyCalcificationsSERMHormoneReplacementTherapyPrecisionMedicineGailModelGeneticPredispositionKi-67RateLumpPhyllodesTumorGeneticCounselingDocetaxelBiopsyMastectomyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.Co-survivorDoxorubicinECOGScoreAdenocarcinomaLumpectomyRelapseAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenImmunotherapyCAMEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearGeneMutationEstradiolBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55mTORInhibitorsCachexiaAdvocacyAromataseInhibitorsFlowCytometryMegestrolAcetatePhysicalactivity mayreduce therisk of breastcancersBRCAGeneAngiogenesisIntraductalPapilloma

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. Cyclophosphamide
  2. Guaranteed Renewable Insurance
  3. Chemoprevention
  4. MRI
  5. Anastrozole
  6. AC Chemotherapy
  7. Cytotoxic
  8. Ovarian Suppression
  9. Tamoxifen
  10. Radiotherapy
  11. In-situ Carcinoma
  12. HER-2
  13. Checkpoint Inhibitor
  14. Multimodality Therapy
  15. Methotrexate
  16. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  17. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  18. Germline Mutation
  19. Ayurveda
  20. Tyrosine-Kinase Inhibitor
  21. Palpation
  22. 5-Fluorouracil
  23. Triple +/- Breast Cancer
  24. Cytostatic
  25. Dose Dense Therapy
  26. Mastodynia
  27. Down-Staging
  28. Estrogen
  29. Morphea
  30. Bevacizumab
  31. CMF Chemotherapy
  32. ER-
  33. CDK4/6 Inhibitors
  34. Oligometastases
  35. Kappa Epsilon
  36. Dimpling
  37. Lymph Node Status
  38. Alopecia
  39. Metastasis
  40. Fibroadenoma
  41. LCIS
  42. Herceptin
  43. Raloxifene
  44. Family History
  45. Staging
  46. Adjuvant Therapy
  47. Lymphoscintigraphy
  48. Absolute Risk
  49. Self-examination
  50. Palbociclib
  51. Paget Disease
  52. Antibody Therapy
  53. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  54. Hormone Receptor Status
  55. Chemotherapy
  56. Cyst
  57. EGFR
  58. Paclitaxel
  59. Pathologic Response
  60. Antiemetic
  61. Definitive Surgery
  62. Breast Tomosynthesis
  63. PARP Inhibitors
  64. RAD
  65. Neoadjuvant Therapy
  66. Apoptosis
  67. BI-RADS
  68. Tumor Grade
  69. 1 in 8 women
  70. Axillary Sampling
  71. Progestin
  72. Multifocal Tumors
  73. Lapatinib
  74. FISH
  75. ER+
  76. PI3 Kinase Inhibitors
  77. Women ages 40+ should have a clinical breast exam at least yearly
  78. Bilateral Prophylactic Mastectomy
  79. Genomic Testing
  80. Capecitabine
  81. Breast Cancer
  82. BOCA
  83. Brachytherapy
  84. Calcifications
  85. SERM
  86. Hormone Replacement Therapy
  87. Precision Medicine
  88. Gail Model
  89. Genetic Predisposition
  90. Ki-67 Rate
  91. Lump
  92. Phyllodes Tumor
  93. Genetic Counseling
  94. Docetaxel
  95. Biopsy
  96. Mastectomy
  97. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  98. Co-survivor
  99. Doxorubicin
  100. ECOG Score
  101. Adenocarcinoma
  102. Lumpectomy
  103. Relapse
  104. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  105. Immunotherapy
  106. CAM
  107. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  108. Gene Mutation
  109. Estradiol
  110. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  111. mTOR Inhibitors
  112. Cachexia
  113. Advocacy
  114. Aromatase Inhibitors
  115. Flow Cytometry
  116. Megestrol Acetate
  117. Physical activity may reduce the risk of breast cancers
  118. BRCA Gene
  119. Angiogenesis
  120. Intraductal Papilloma